Key result
Pulsed field ablation is linked to an absolute ~10-point reduction in left atrial enhancement by 90 days.
Why the study?
Data regarding acute lesion characteristics and lesion maturation after pulsed field ablation for pulmonary vein isolation remain limited.
Does focal point-by-point pulsed field ablation result in substantial temporal changes in left atrial enhancement and lesion maturation as measured by serial LGE-CMR in patients with atrial fibrillation?
Observational (n=6)
Does focal point-by-point pulsed field ablation result in substantial temporal changes in left atrial enhancement and lesion maturation as measured by serial LGE-CMR in patients with atrial fibrillation?
Serial LGE-CMR demonstrates that acute enhancement following focal pulsed field ablation for pulmonary vein isolation substantially reduces by 90 days, with mature lesions remaining localized to targeted areas.
Answers are grounded in this paper and cite their sources.
Supports localized lesion maturation without remodeling after focal PFA; hypothesis-generating pending larger prospective validation.
Background Pulsed field ablation (PFA) has emerged as a novel non-thermal ablation modality for pulmonary vein isolation (PVI) in atrial fibrillation (AF). While chronic lesion formation after PFA has been described, data regarding acute lesion characteristics and lesion maturation remain limited. Objective To characterize acute and chronic lesion formation following focal point-by-point PFA for PVI using serial late-gadolinium-enhancement cardiovascular-magnetic-resonance-imaging (LGE-CMR). Methods Six consecutive patients with symptomatic paroxysmal or persistent AF underwent index PFA-guided PVI using the CENTAURI system and a focal point-by-point lesion delivery strategy. LGE-CMR was performed 1 day and 90±10 days after ablation. Quantitative assessment of regional and global left atrial (LA) enhancement was performed using a standardized segmentation protocol. Changes in enhancement burden and LA dimensions were analyzed between imaging timepoints. Results Among six patients at mean age 65±7 years, five patients (83%) had paroxysmal AF. Acute PVI was achieved in all patients without procedural complications. Serial LGE-CMR demonstrated substantial temporal changes between acute and chronic imaging. Enhancement within the right pulmonary vein (PV) region decreased from 3.3±2.2% to 0.8±0.8%(p=0.030), while the proportion of enhanced tissue decreased from 24.1±13.5% to 5.7±5.8%(p=0.017). Similar reductions were observed around the left PVs (4.4±3.1%vs.1.4±1.2%, p=0.064). Posterior wall enhancement decreased from 2.4±1.1% to 0.3±0.3%(p=0.007) and global LA enhancement from 12.8±6.2% to 3.3±1.6%(p=0.013), while LA volume remained unchanged. Conclusion Serial LGE-CMR demonstrated substantial enhancement reduction of acute lesions following focal point-by-point PFA for PVI, which remained largely confined to the PV antra and adjacent posterior wall, providing novel in-human insights into lesion maturation following focal PFA delivery.
No takes yet. Share an insight, caveat, or question.
Moersdorf et al. (2026) conducted an observational in Symptomatic paroxysmal or persistent atrial fibrillation (n=6). Focal point-by-point pulsed field ablation vs. Acute imaging (1 day post-ablation) was evaluated on Global left atrial (LA) enhancement on LGE-CMR (p=0.013). Following focal point-by-point pulsed field ablation, serial LGE-CMR showed a significant reduction in global left atrial enhancement from 12.8% at 1 day to 3.3% at 90 days.
Synapse has enriched 10 related papers. Consider them for comparative context: